Instil Bio (TIL) Receivables - Other (2020 - 2026)

Instil Bio has reported Receivables - Other for 6 years, with the latest figure at $26000.0 in Q2 2026.

• On a quarterly basis, Receivables - Other fell 96.77% year-over-year to $26000.0 in Q2 2026; TTM through Jun 2026 was $26000.0, a 96.77% decrease from a year earlier, with the FY2025 full-year figure at $848000.0, down 67.66% from the prior year.
• Receivables - Other was $26000.0 for Q2 2026 at Instil Bio, down from $28000.0 in the prior quarter.
• The five-year high for Receivables - Other was $3.6 million in Q4 2023, with the low at $26000.0 in Q2 2026.
• Average Receivables - Other over 4 years is $1.5 million, with a median of $845500.0 recorded in 2025.
• The sharpest annual moves came in 2024 and 2026: Receivables - Other decreased 28.03% in 2024, then slumped 96.77% in 2026.
• Over 4 years, Receivables - Other stood at $3.6 million in 2023, then fell by 28.03% to $2.6 million in 2024, then tumbled by 67.66% to $848000.0 in 2025, then slumped by 96.93% to $26000.0 in 2026.
• The last three Receivables - Other figures came in at $26000.0 (Q2 2026), $28000.0 (Q1 2026), and $848000.0 (Q4 2025), per Business Quant data.